Bollen, L <br/><br/>
Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.  [electronic resource] 

 -  Clinical & experimental metastasis  Jan 2015 
 - 1-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1573-7276 
<br/><br/><label>Standard No.: </label>10.1007/s10585-014-9685-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--metabolism<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Middle Aged<br/>Phenotype<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retrospective Studies<br/>Spinal Neoplasms--mortality<br/>Triple Negative Breast Neoplasms--metabolism